Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Studies of the Transmission Dynamics, Mathematical Model Development and the Control of Schistosome Parasites by Mass Drug Administration in Human Communities
Roy M. Anderson, Hugo C. Turner, Sam H. Farrell, et al.
Advances in Parasitology/Advances in parasitology (2016), pp. 199-246
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
Jaspreet Toor, Ramzi Alsallaq, James E. Truscott, et al.
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S245-S252
Open Access | Times Cited: 100
The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission
Sam H. Farrell, James E. Truscott, Roy M. Anderson
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 67
The Global State of Helminth Control and Elimination in Children
Jill E. Weatherhead, Peter J. Hotez, Rojelio Mejía
Pediatric Clinics of North America (2017) Vol. 64, Iss. 4, pp. 867-877
Open Access | Times Cited: 67
The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
Jaspreet Toor, Hugo C. Turner, James E. Truscott, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 10, pp. e0006717-e0006717
Open Access | Times Cited: 61
Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
Klodeta Kura, Diepreye Ayabina, Jaspreet Toor, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 3, pp. 236-244
Open Access | Times Cited: 36
Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations
Hugo C. Turner, James E. Truscott, Alison A. Bettis, et al.
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 46
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
Klodeta Kura, James E. Truscott, Jaspreet Toor, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 6, pp. e0007349-e0007349
Open Access | Times Cited: 37
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
Jaspreet Toor, David Rollinson, Hugo C. Turner, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. Supplement_5, pp. S525-S530
Open Access | Times Cited: 37
Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
Klodeta Kura, Diepreye Ayabina, T. Déirdre Hollingsworth, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs
Kathryn Forbes, María‐Gloria Basáñez, T. Déirdre Hollingsworth, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1887
Open Access | Times Cited: 11
How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?
Klodeta Kura, Nyamai Mutono, María‐Gloria Basáñez, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S126-S130
Open Access | Times Cited: 4
A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis
James E. Truscott, David Gurarie, Ramzi Alsallaq, et al.
Epidemics (2017) Vol. 18, pp. 29-37
Open Access | Times Cited: 36
Testing for soil-transmitted helminth transmission elimination: Analysing the impact of the sensitivity of different diagnostic tools
Marleen Werkman, James E. Wright, James E. Truscott, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 1, pp. e0006114-e0006114
Open Access | Times Cited: 34
Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis
Luc E. Coffeng, Matthew Graham, Raiha Browning, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S153-S159
Open Access | Times Cited: 3
Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique
Anna E. Phillips, Pedro Henrique Gazzinelli-Guimarães, Herminio O. Aurelio, et al.
PLoS neglected tropical diseases (2017) Vol. 11, Iss. 12, pp. e0006061-e0006061
Open Access | Times Cited: 29
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
Klodeta Kura, Robert J. Hardwick, James E. Truscott, et al.
Parasites & Vectors (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 26
SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
Matthew Graham, Diepreye Ayabina, Tim Lucas, et al.
Infectious Disease Modelling (2021) Vol. 6, pp. 438-447
Open Access | Times Cited: 23
Baseline soil-transmitted helminth and schistosome infection in the Geshiyaro project, Ethiopia: A unique transmission interruption project using biometric fingerprinting for longitudinal individual analysis
Anna E. Phillips, Alison Ower, Kalkidan Mekete, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 10, pp. e0011589-e0011589
Open Access | Times Cited: 8
Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
Andria Stylianou, Christoforos Hadjichrysanthou, James E. Truscott, et al.
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Zoonotic transmission of intestinal helminths in southeast Asia: Implications for control and elimination
Martha Betson, Allen Jethro I. Alonte, Rico Ancog, et al.
Advances in Parasitology/Advances in parasitology (2020), pp. 47-131
Open Access | Times Cited: 21
Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme
Charlotte Gower, Florian Gehre, Sara R. Marques, et al.
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 23
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
Jaspreet Toor, James E. Truscott, Marleen Werkman, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Progress in controlling the transmission of schistosome parasites in Southern Ethiopia: the Geshiyaro Project in the Wolaita Zone
Birhan Mengistu, Ewnetu Firdawek Liyew, Melkie Chernet, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Threshold dynamics of a reaction–advection–diffusion schistosomiasis epidemic model with seasonality and spatial heterogeneity
Peng Wu, Yurij Salmaniw, Xiunan Wang
Journal of Mathematical Biology (2024) Vol. 88, Iss. 6
Open Access | Times Cited: 2
Vaccine value profile for schistosomiasis
Gavin Yamey, Kaci Kennedy McDade, Roy M. Anderson, et al.
Vaccine (2024), pp. 126020-126020
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top